Scailyte

Curated by Signal

Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery

Overview

Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery. The company is developing AI software for single-cell data analysis to discover novel biomarkers for the early and precise detection of a wide range of complex diseases. This AI-based single-cell technology can also be used for the identification of relevant single-cell patterns from mass cytometry data.

Key facts

Founded: 2017
Headquarters: Lucerne, Switzerland
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

BC Platforms
Provider of a platforms for genomic data analysis and management
Life Sciences TechnologyZurich, Switzerland
SIVA Health
Provider of continuous ambulatory cough measurement devices for hospitals and patients
Life Sciences TechnologyZurich, Switzerland
Epigee
Provider of AI and data analytics based biological-aging measuring tool
Life Sciences TechnologySt. Gallen, Switzerland

About Scailyte

What does Scailyte do?

Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery.

Where is Scailyte headquartered?

Scailyte is headquartered in Lucerne, Switzerland.

When was Scailyte founded?

Scailyte was founded in 2017.

Which sector is Scailyte in?

Scailyte operates in Life Sciences Technology.

Who are Scailyte's competitors?

Companies similar to Scailyte include BC Platforms, SIVA Health, and Epigee.